Agios Pharmaceuticals’ Post

View organization page for Agios Pharmaceuticals, graphic

80,047 followers

We recently announced that we are entering into a distribution agreement with NewBridge Pharmaceuticals, a leading specialty company headquartered in Dubai, to advance regulatory filings and commercialization of PYRUKYND® (mitapivat) in the Gulf Cooperation Council (GCC) region. There is a large population of patients within the GCC region, and this agreement will help ensure more treatment options are available for those living with #rarediseases. NewBridge has rights to eventually commercialize PYRUKYND® in Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates. 

  • No alternative text description for this image
Islam Othman

National Medical Science Liaison |11+ Years in Pharma |Hematology, Rare Diseases & GIT | Enhancing Lives Through Science

2mo

Iam intersted to join the team if there is opportunity to excel my extensive experiance in hematology & SCD across all the kingdom of saudi arabia for about 8 years of experiance. Kindly, if there is availability let me know and i can share my detailed cv. With the hiring manager & discus also. Accept my warm congratulations & best of luck 🌷 NewBridge Pharmaceuticals Agios Pharmaceuticals

Catherine Owen Adams

Chief Executive Officer, Global P&L Leader, Board Director for public and private companies

2mo

Exciting news for patients in GCC. Great partnership achieved with NewBridge, congratulations Tsveta Milanova and team!

See more comments

To view or add a comment, sign in

Explore topics